Stock Mumak

Stock Profile

Uranium Energy

Uranium Energy (UEC) positions itself as a strategic platform in the US uranium market. With a debt-free balance sheet, the stock offers high optionality on the nuclear cycle.

Stock Snapshot

Table HeaderTable Header
CompanyUranium Energy Corp.
SectorEnergy
ThemeNuclear Fuel (Uranium)
Business ModelUranium exploration, ISR production (In-Situ Recovery), and the establishment of a US-based nuclear fuel value chain
ISINUS9168961038
Market Capitalizationapprox. USD 5.6 billion
UMBRELLA StatusActive

Uranium Energy Corp. is a U.S. uranium company focused on ISR production, uranium inventory management, and building a domestic nuclear fuel platform.

The company operates a hub-and-spoke production model in Texas and Wyoming and is increasingly developing into an integrated player within the U.S. uranium supply chain.

Unlike traditional mining companies, UEC is not only a producer but also a strategic resource platform that benefits from uranium price movements as well as the value of its inventories and politically driven demand.

→ Key variable: Uranium price + demand for nuclear energy + energy and supply security policy

Price Performance (12 Months)

Mumak Score Card

Geopolitics

Industry

Fundamentals

Sentiment

Technical Analysis

Aktuelle Unternehmensmeldungen

UEC
Valuation Analysis

Valuation Analysis: Uranium Energy

ISIN: US9168961038

Uranium Energy Corp. benefits from strong geopolitical tailwinds by focusing on US supply security. As a debt-free uranium producer with a focus on ISR mining and significant reserves, the company offers massive leverage to rising uranium prices. Despite a current transitional phase in earnings quality, the company is strategically ideally positioned for the global nuclear trend.
Compass 4 out of 5
More research

Latest Portfolio Updates

Eli Lilly
Company Update

Eli Lilly – Q2 2026 Earnings Update

Eli Lilly grows rapidly in the second quarter of 2026: Revenue rises 48 percent, Mounjaro and Zepbound skyrocket, full-year guidance
Next Update
Bayer
Company Update

Bayer – Q2 2026 Earnings Update

Bayer increases revenue and operating earnings in Q2 2026 and confirms its full-year targets despite legal risks.
Next Update
Johnson & Johnson
Company Update

Bayer – Q2 2026 Earnings Update

Johnson & Johnson impresses with strong Q2 2026 figures, significantly increasing revenue and free cash flow while raising its guidance
Next Update
Weekly Update

Weekly Market Overview – July 27-August 2, 2026

The market overview shows why strong figures from Apple, Rheinmetall, and other companies are not always enough for price gains.
Next Update